Document Detail


High Sensitivity C-Reactive Protein and Outcomes Following Percutaneous Coronary Intervention in Contemporary Practice.
MedLine Citation:
PMID:  23212397     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
BACKGROUND: HIGH SENSITIVITY C-REACTIVE PROTEIN (HSCRP) HAS BEEN IDENTIFIED AS A PREDICTOR OF ADVERSE CARDIOVASCULAR OUTCOMES. WHETHER HSCRP IS A USEFUL BIOMARKER FOR RISK STRATIFICATION IN CONTEMPORARY PERCUTANEOUS CORONARY INTERVENTION REMAINS UNKNOWN.METHODS AND RESULTS: WE CONDUCTED A PROSPECTIVE STUDY AMONG 513 PATIENTS UNDERGOING NON-EMERGENCY PERCUTANEOUS CORONARY INTERVENTION AND EXAMINED THE RELATIONSHIP BETWEEN PRE- AND POSTPROCEDURAL HSCRP LEVELS AND OUTCOMES. THE PATIENTS WERE DIVIDED ACCORDING TO THE MEDIAN PREPROCEDURAL HSCRP LEVEL (0.3 MG/DL). PATIENTS WITH HIGH HSCRP HAD SIGNIFICANTLY MORE ADVERSE CLINICAL CHARACTERISTICS. PREPROCEDURAL HSCRP LEVEL WAS AN INDEPENDENT PREDICTOR OF PERIPROCEDURAL MYOCARDIAL INFARCTION (ODDS RATIO PER DOUBLING OF HSCRP 1.15 [95% CONFIDENCE INTERVAL, 1.011.31]; P=0.038). UNADJUSTED MORTALITY (29.7% VERSUS 9.9%; P0.001) AND THE COMBINED END POINT OF DEATH OR MYOCARDIAL INFARCTION (36.5% VERSUS 16.0%, P0.001) DURING A FOLLOW-UP OF 5 YEARS WERE MARKEDLY GREATER IN PATIENTS WITH HIGH PREPROCEDURAL HSCRP. SIMILAR RELATIONSHIPS EXISTED FOR POSTPROCEDURAL HSCRP. HOWEVER, AFTER MULTIVARIABLE ADJUSTMENT, NEITHER PREPROCEDURAL HSCRP LEVELS (HAZARD RATIO PER DOUBLING 0.96 [0.92, 1.00]; P=0.066) NOR POSTPROCEDURAL HSCRP LEVELS (HAZARD RATIO 0.98 [0.94, 1.02]; P=0.27) WERE SIGNIFICANTLY ASSOCIATED WITH MORTALITY.CONCLUSIONS: High hsCRP is associated with a greater independent risk of periprocedural myocardial infarction, as defined by the universal definition, but is not an independent determinant of mortality after percutaneous coronary intervention. Our findings suggest that routine measurement of hsCRP in patients undergoing percutaneous coronary intervention in contemporary practice is unlikely to be beneficial.
Authors:
Joerg Herrmann; Ryan J Lennon; Gregory W Barsness; Gurpreet S Sandhu; Rajiv Gulati; Patricia J M Best; Paul Sorajja; John F Bresnahan; Verghese Mathew; Malcolm R Bell; Abhiram Prasad
Related Documents :
23258137 - Non-invasive cardiac index monitoring during cardiopulmonary functional testing provide...
23084247 - Temporal changes in phosphatidylserine expression and glucose metabolism after myocardi...
15855087 - Mdct evaluation of the coronary arteries, 2004: how we do it--data acquisition, postpro...
25089927 - Preinfarction angina: clinical significance and relationship with total ischemic time i...
24780447 - Targeting matrix metalloproteinases in heart disease: lessons from endogenous inhibitors.
6218967 - St-t segment changes in patients with essential hypertension.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-12-4
Journal Detail:
Title:  Circulation. Cardiovascular interventions     Volume:  -     ISSN:  1941-7632     ISO Abbreviation:  Circ Cardiovasc Interv     Publication Date:  2012 Dec 
Date Detail:
Created Date:  2012-12-5     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101499602     Medline TA:  Circ Cardiovasc Interv     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Division of Cardiovascular Diseases, Department of Medicine and the Division of Biomedical Statistics and Informatics, Mayo Clinic and Mayo Foundation, Rochester, MN.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Pressure-Diameter Relationship in Human Coronary Arteries.
Next Document:  What are the Factors Predictive of Hysterosalpingogram Compliance After Female Sterilization by the ...